Colgate-Palmolive (CL) Stock Forecast & Price Target

$93.56 +2.11 (+2.31%)

(As of 11/15/2024 ET)

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
1

Hold
9

Buy
12

Based on 22 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 9 have given a hold rating, and 12 have given a buy rating for CL.

Consensus Price Target

$105.11
12.34% Upside

According to the 22 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $105.11. The highest price target for CL is $122.00, while the lowest price target for CL is $91.00. The average price target represents a forecasted upside of 12.34% from the current price of $93.56.

CL Analyst Ratings Over Time

Type	Current Forecast 11/17/23 to 11/16/24	1 Month Ago 10/18/23 to 10/17/24	3 Months Ago 8/19/23 to 8/18/24	1 Year Ago 11/17/22 to 11/17/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	13 Buy rating(s)	13 Buy rating(s)	8 Buy rating(s)
Hold	9 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$105.11	$106.00	$101.11	$82.57
Forecasted Upside	12.34% Upside	5.45% Upside	-0.87% Downside	9.26% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Tech funds are hemorrhaging cash: Sell this stock now (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.50	2.46	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	12.32% Upside	236.80% Upside	9.85% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/28/2024	Wells Fargo & Company 3 of 5 stars	C. Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Underweight ➝ Underweight	$100.00 ➝ $92.00	-4.42%
10/28/2024	TD Cowen 4 of 5 stars	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$115.00 ➝ $110.00	+16.40%
10/28/2024	Stifel Nicolaus 4 of 5 stars		Downgrade	Buy ➝ Hold	$105.00 ➝ $101.00	+5.64%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$113.00 ➝ $114.00	+14.87%
9/24/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$121.00	+17.12%
9/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$107.00 ➝ $109.00	+1.06%
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad) If you missed out on Nvidia, watch this BEFORE November 19th. Click here for the full video
9/4/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$119.00 ➝ $122.00	+11.95%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$100.00 ➝ $103.00	+3.00%
7/29/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$103.00 ➝ $111.00	+10.46%
7/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$91.00 ➝ $96.00	-4.61%
7/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$103.00 ➝ $112.00	+15.00%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
4/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$88.00 ➝ $95.00	+4.38%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%
1/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$91.00	+9.86%
11/21/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:36 PM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 31, 2024. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive had a return on equity of 470.19%, indicating strong profitability and efficient use of shareholder funds.
The company's revenue was up 4.9% on a year-over-year basis, showing consistent growth in its top line.
Colgate-Palmolive announced a quarterly dividend of $0.50 per share, reflecting a dividend yield of 1.94% which can provide investors with a steady income stream.
Research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year, suggesting positive earnings growth.
Insiders have sold shares of the company's stock worth $4,486,063 in the last 90 days, indicating confidence in the company's future performance.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

Colgate-Palmolive's stock traded down to $101.97, which may indicate short-term volatility or market concerns affecting the stock price.

CL Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $105.11, with a high forecast of $122.00 and a low forecast of $91.00.
: 22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There is currently 1 sell rating, 9 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CL shares.
: According to analysts, Colgate-Palmolive's stock has a predicted upside of 12.34% based on their 12-month stock forecasts.
: Over the previous 90 days, Colgate-Palmolive's stock had 3 downgrades by analysts.
: Colgate-Palmolive has been rated by research analysts at Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Piper Sandler, Stifel Nicolaus, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad)

If you missed out on Nvidia, watch this BEFORE November 19th.

Click here for the full video

This page (NYSE:CL) was last updated on 11/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target